![Biomolecules | Free Full-Text | Pompe Disease: New Developments in an Old Lysosomal Storage Disorder Biomolecules | Free Full-Text | Pompe Disease: New Developments in an Old Lysosomal Storage Disorder](https://pub.mdpi-res.com/biomolecules/biomolecules-10-01339/article_deploy/html/images/biomolecules-10-01339-g001.png?1600686172)
Biomolecules | Free Full-Text | Pompe Disease: New Developments in an Old Lysosomal Storage Disorder
![Effect of alglucosidase alfa dosage on survival and walking ability in patients with classic infantile Pompe disease: a multicentre observational cohort study from the European Pompe Consortium - The Lancet Child & Effect of alglucosidase alfa dosage on survival and walking ability in patients with classic infantile Pompe disease: a multicentre observational cohort study from the European Pompe Consortium - The Lancet Child &](https://www.thelancet.com/cms/asset/b90f8362-1404-4965-ae06-2c7a3c81bdce/gr1.jpg)
Effect of alglucosidase alfa dosage on survival and walking ability in patients with classic infantile Pompe disease: a multicentre observational cohort study from the European Pompe Consortium - The Lancet Child &
Long-Term Prognosis of Patients with Infantile-Onset Pompe Disease Diagnosed by Newborn Screening and Treated since Birth
![Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase - ScienceDirect Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525001620302896-fx1.jpg)
Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase - ScienceDirect
![Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy | Orphanet Journal of Rare Diseases | Full Text Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy | Orphanet Journal of Rare Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1750-1172-6-34/MediaObjects/13023_2011_Article_303_Fig1_HTML.jpg)
Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy | Orphanet Journal of Rare Diseases | Full Text
![Muscle‐directed gene therapy corrects Pompe disease and uncovers species‐specific GAA immunogenicity | EMBO Molecular Medicine Muscle‐directed gene therapy corrects Pompe disease and uncovers species‐specific GAA immunogenicity | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/a2942442-98b3-4a59-963b-97985b17a85d/emmm202113968-abs-0001-m.jpg)